* WELL Health Technologies Corp WELL.TO is expected
to show a
rise in quarterly revenue when it reports results on March 31.
* The Vancouver British Columbia-based company is expected
to
report a 556.2% increase in revenue to C$112.793 million from
C$17.19 million a year ago, according to the mean estimate from
12 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for WELL Health
Technologies
Corp is for a loss of 3 cents per share. For the same quarter
last year, the company reported earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for WELL Health
Technologies Corp is C$10.5, above its last closing price
of C$4.58.
* Previous quarterly performance (using preferred earnings
measure
in Canadian dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.01 0.00 -0.06 Missed -1,100
Jun. 30 2021 -0.02 -0.02 -0.08 Missed -414.1
Mar. 31 2021 -0.02 -0.02 -0.04 Missed -128.6
Dec. 31 2020 -0.02 -0.02 0.04 Beat 357.1
Sep. -0.02 -0.02 -0.03 Missed -80
30 2020
Jun. 30 2020 -0.02 -0.02 -0.03 Missed -50
Mar. 31 2020 -0.02 -0.02 -0.02 Met -9.1
Dec. 31 2019 -0.02 -0.02 0.00 Beat 100
This summary was machine generated March 29 at 12:53 GMT. All
figures in Canadian dollars unless otherwise stated